Latest filing published 07 Oct 2024 for CARMAT, €18k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Paolo Rampulla discloses dealings in 2 companies, chiefly Abivax and Carmat. Over a trading history stretching from 13 November 2023 to 2 October 2024, the count stands at 2 filings.
Every open-market trade on record is a purchase: 1 purchase worth €40, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 7 October 2024 with a transaction (€18k) in Carmat. The most recent open-market purchase was published on 14 November 2023, 1,068 days ago. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations